ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BGS announcements B&g Foods, Inc. announcements and dividends declared NYSE

B&g Foods, Inc. Complete list of announcements declared & dividend announcements by B&g Foods, Inc. BGS

B&g Foods, Inc. BGS listed on NYSE and deals in Consumer Non Durables Packaged Foods

Announcements and dividends declared by B&g Foods, Inc. BGS

Pfizer Announces Positive Results From Late-stage Study Of Hemophilia B Gene Therapy Candidate
(RTTNews) - Pfizer Inc. (PFE) announced positive results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene elaparvovec, an investigational gene therapy, for the treatment of adult males with moderately severe to severe hemophilia B.
Announcement as on 29 December 2022

China reopening to curb growth: Goldman President
Goldman Sachs Group Inc. President John Waldron said China's road to reopening could be "bumpy," which coupled with the scenario of a mild recession in Europe and the US could lead to a tougher economic climate.
Announcement as on 10 December 2022

PNB gets Centre's approval to divest its entire stake in UTI AMC
The bank holds 15.22 per cent stake in UTI AMC worth around Rs 1300 crore at current valuation
Announcement as on 24 November 2022

AbbVie (ABBV) BLA for Epcoritamab Gets FDA Priority Tag
AbbVie ABBV and partner Genmab GMAB announced that the FDA has accepted and granted priority review to its biologics license application (BLA) seeking approval for epcoritamab for the treatment of relapsed/refractory large B-cell lymphoma (LBCL) after two
Announcement as on 22 November 2022

AbbVie (ABBV) BLA for Epcoritamab Gets FDA Priority Tag
AbbVie ABBV and partner Genmab GMAB announced that the FDA has accepted and granted priority review to its biologics license application (BLA) seeking approval for epcoritamab for the treatment of relapsed/refractory large B-cell lymphoma (LBCL) after two
Announcement as on 22 November 2022

Announcements by B&g Foods, Inc. first page | Next page | Prev page |

BGS B&g Foods, Inc. current price & indicator signals

Moving Averages for B&g Foods, Inc.

  • 5Day Average: 3.52
  • 12Day Average: 3.56
  • 20Day Average: 3.61
  • 50Day Average: 3.82
  • 100Day Average: 4.42
  • 150Day Average: 4.56
  • 200Day Average: 4.54

BGS Indicators & signals

Indicator MACD (12,26,9)

3.56, 3.68, -0.12
Indicator MACD is in negative zone

Indicator ADX (14)

0, 50, 50
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BGS B&g Foods, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
07 Fri Aug 2026 3.52 3.42 to 3.52 2.62% 1.2 times
06 Thu Aug 2026 3.43 3.42 to 3.54 -2.56% 1.1 times
05 Wed Aug 2026 3.52 3.42 to 3.56 -1.12% 1.64 times
04 Tue Aug 2026 3.56 3.52 to 3.59 -0.28% 0.9 times
03 Mon Aug 2026 3.57 3.50 to 3.61 1.13% 0.98 times
31 Fri Jul 2026 3.53 3.52 to 3.60 -2.22% 0.8 times
30 Thu Jul 2026 3.61 3.57 to 3.75 -3.22% 1.3 times
29 Wed Jul 2026 3.73 3.66 to 3.79 1.91% 1.1 times
28 Tue Jul 2026 3.66 3.62 to 3.73 2.23% 1.04 times
27 Mon Jul 2026 3.58 3.52 to 3.60 1.7% 0.69 times
24 Fri Jul 2026 3.52 3.50 to 3.58 0% 0.47 times
24 Fri Jul 2026 3.52 3.50 to 3.58 0.28% 0.47 times

Videos related to: BGS announcements B&g Foods, Inc. announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

BGS announcements B&g Foods, Inc. announcements and dividends declared NYSE

 

Back to top